ArticleFrontiers in pediatrics2026
Necrotizing enterocolitis in very preterm infants: an epidemiological study in Jiangsu, China.
Article in Frontiers in pediatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Epidemiological data focusing on clinical practices for necrotizing enterocolitis (NEC) in China remains scarce. To characterize the incidence, clinical management, and outcomes of NEC among very preterm infants (VPIs) in China. Methods: This study included all VPIs (gestational age <32 weeks) admitted to seven hospitals in Jiangsu, China between 2019 and 2021. Infants who died or were discharged within 72 h were excluded. NEC was defined as Bell's stage ≥ II. Results: Among 3,088 included infants, NEC incidence was 5.1% (156/3,088), decreasing with advancing gestational age: 7.7% at <28 weeks, 5.8% at 28-29 weeks, and 3.7% at 30-31 weeks. The rates of key perinatal/neonatal practices were 78.1% for antenatal steroids, 17.7% for delayed cord clamping, and 52.1% for human milk feeding. Among 156 NEC cases, NEC mortality was 16.7% (26/156), peaking at 30% in <28w group. Median nil per os duration was 8 (IQR: 5-11) days and time to full feeds was 25 (IQR: 14-38) days post-onset. Only 18.0% were initiated any human milk feeding after the NEC-related fasting period. Median antibiotic duration for NEC was 17 (IQR: 11-26) days, and 51.9% of cases received carbapenems. Conclusions: Overall NEC incidence and mortality in VPIs were comparable to high-income country benchmarks; however, the 28-31 week subgroup showed higher incidence than these benchmarks, whereas the <28 week subgroup showed higher mortality. These findings highlight the importance of gestational-age-stratified interpretation and may inform future quality improvement efforts in perinatal care, human milk feeding, and antibiotic stewardship.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.